Pathomolecular effects of homocysteine on the aging process: A new theory of aging

Medical Hypotheses

Volumn 69, Issue 1, 2007, Pages 149-160

  Perez, Felipe P ^a   Ilie, John I ^a   Zhou, Ximing ^a   Feinstein, Douglas ^a   Jurivich, Donald A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; HOMOCYSTEINE;

AGING; ARTICLE; BONE DISEASE; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; DIET RESTRICTION; DISEASE ASSOCIATION; GENOME; HOMOCYSTINURIA; HUMAN; LIFESPAN; NEUROLOGIC DISEASE; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS;

AGING; ANIMALS; HOMOCYSTEINE; HUMANS; MODELS, BIOLOGICAL;

EID: 34247564563     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.10.056     Document Type: Article

References (127)

1. Kirkwood T.B.L. Genetic basis of limited cell proliferation. Mut Res 256 58 (1991) 323-328
2. Holliday R. Understanding aging (1996), Cambridge University Press, Cambridge (UK)
3. Yu C.E., Oshima J., Fu Y.H., et al. Positional cloning of the Werner's syndrome gene. Science 272 (1996) 258-262
4. Ellis N.A., Groden J., Ye T.Z., et al. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 83 (1995) 655-666
5. Amouyel P. Genetic susceptibility to ageing-associated diseases. C R Biol 325 (2002) 741-745
6. Sunghoon K. Molecular biology of aging. Arch Surg 138 (2003) 1051-1054
7. Krumdieck C.L., and Prince C.W. Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging. J Nutr 130 (2000) 365S-368S
8. Finkelstein J.D. Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost 26 (2000) 219-225
9. Refsum H., Ueland P.M., Nygård O., and Vollset S.E. Homocysteine and cardiovascular disease. Annu Rev Med 49 (1998) 31-62
10. Ueland P.M. Homocysteine species as components of plasma redox thiol status. Clin Chem 41 (1995) 340-342
11. Mansoor M.A., Ueland P.M., Aarsland A., and Svardal A. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria. Metabolism 42 (1993) 1481-1485
12. Hultberg B., Andersson A., and Isaksson A. Hypomethylation as a cause of homocysteine-induced cell damage in human cell lines. Toxicology 147 (2000) 69-75
13. Hoffman D.R., Cornatzer W.E., and Duerre J.A. Relationship between tissue levels of S-adenosylmethionine, and S-adenylhomocysteine. Can J Biochem 57 (1979) 56-65
14. Mathers J.C. Reversal of DNA hypomethylation by folic acid supplements: possible role incolorectal cancer prevention. Gut 54 5 (2005) 579-581
15. Roach H., Yamada N., Cheung K., Tilley S., Clarke N., Oreffo R., et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 52 10 (2005) 3110-3124
16. Dudman N.P.B., Hicks C., Lynch J.F., Wilken D.E.L., and Wang J. Homocysteine thiolactone disposal by human arterial endothelial cells and serum in vitro. Arterioscl Thromb 11 (1991) 663-670
17. Lorenco de Koning A.B., Werstuck G.H., Zhou J., and Austin R.C. Hyperhomocysteinemia and its role in the development of atherosclerosis. Clin Biochem 36 (2003) 431-441
18. Jakubowski H. Translational incorporation of S-nitrosohomocysteine into protein. J Biol Chem 275 (2000) 21813-21816
19. Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated hcy levels. FASEB J 13 (1999) 2277-2283
20. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures. J Biol Chem 272 (1997) 1935-1942
21. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15 (1992) 1835-1843
22. Pyeritz R.E. The Marfan syndrome. Connective tissue and its heritable disorders (1993), Wiley-Liss, New York (NY) p. 437-68
23. Rosenberger R.F. Senescence and the accumulation of abnormal proteins. Mut Res 256 2-6 (1991) 255-262
24. Pirlet K., and Arthur-Goettig A. Maintaining life and health by natural selection of protein molecules. J Theor Biol 201 (1999) 75-85
25. Stadman E.R. Covalent modification reactions are marking steps in protein turnover. Biochemistry 29 (1990) 6321-6331
26. Berlett B.S., and Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272 (1997) 20313-20316
27. Stern F., Berner Y., Polyak Z., Komarnitskya M., Sela B., Hopp M., et al. Homocysteine effect on protein degradation rates. Clin Biochem 37 11 (2004) 1002-1009
28. Verdile G., et al. Protein markers for Alzheimer disease in the frontal cortex and cerebellum. Neurology 63 8 (2004) 1385-1392
29. Jacobsen D.W. Practical chemistry of homocysteine and other thiols. In: Carmel R., and Jacobsen D.W. (Eds). Homocysteine in health and disease (2001), Cambridge Univ Press, Cambridge 9-20
30. Togawa T., Sengupta S., Chen H., et al. Mechanisms for the formation of protein-bound homocysteine in human plasma. Biochem Biophys Res Commun 277 (2000) 668-674
31. Jakubowski H. Protein N-homocysteinylation: implications for atherosclerosis. Biomed Pharmacother 55 (2001) 443-447
32. Rivett A.J., and Gardner R.C. Proteasome inhibitors: from in vitro uses to clinical trials. J Pept Sci 6 (2000) 478-488
33. Holbrook N.J., and Udelsman R. In: Morimoto R.I., Tissières A., and Georgopoulos C. (Eds). The biology of heat shock proteins and molecular chaperones (1994), Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY) 577-593
34. Heydari A.R., Takahashi T., Gutsmann A., You S., and Richardson A. Experientia 50 (1994) 1092-1098
35. Wheeler J.C., Bieschke E.T., and Tower J. Proc Natl Acad Sci USA 92 (1995) 10408-10412
36. Walker G.A., and Lithgow G. Lifespan extension in C. elegans by a molecular chaperone dependent upon insulin-like signals. Aging Cell 2 (2003) 131
37. Kroll J. The molecular chaperones and the phenomena of cellular immortalization and apoptosis in vitro. Ann NY Acad Sci 1019 (2004) 568-571
38. Hsu A.-L., Murphy C.T., and Kenyon C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 300 (2003) 1142-1145
39. Outinen P., Sood S., Liaw P., Sarge K., Maeda N., Hirsh J., et al. Characterization of the stress-inducing effects of hcy. Biochem J 332 (1998) 213
40. Manalo D.J., and Liu A.Y.-C. Resolution, detection, and characterization of redox conformers of human HSF1. J Biol Chem 276 26 (2001) 23554-23561
41. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., et al. Plasma HC as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346 (2002) 476-483
42. Faraci F., and Didion S. Vascular protection: superoxide dismutase isoforms in the vessel wall. Art Thr Vasc Biol 24 8 (2004) 1367
43. Sohal R.S., and Weindruch R. Oxidative stress, caloric restriction, and aging. Science 273 (1996) 59-63
44. Agarwal R.S., and Sohal R.S. Relationship between susceptibility to protein oxidation, aging, and maximum life span of different species. Exp Gerontol 31 (1996) 365-372
45. Widner B., Enzinger C., Laich A., Wirleitner B., and Fuchs D. Hyperhomocysteinemia, pteridines and oxidative stress. Curr Drug Metab 3 (2002) 22532
46. Sawle P., Foresti R., Green C.J., et al. Homocysteine attenuates endothelial haem oxygenase-1 induction by nitric oxide (NO) and hypoxia. FEBS Lett 508 (2001) 403-406
47. Outinen P.A., Sood S.K., Pfeifer S.I., et al. Homocysteine-induced endoplasmic reticulum stress and growth arrest. Blood 94 (1999) 959-967
48. Yi F., Zhang A., Janscha J., Li P., and Zou A. Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. Kidney Intern 66 5 (2004) 1977-1987
49. Weiss N., Zhang Y.Y., Heydrick S., et al. Overexpression of cellular glutathione peroxidase rescues homocysteine-induced endothelial dysfunction. Proc Natl Acad Sci USA 98 (2001) 12503-12508
50. Kaufman R.J. Orchestrating the unfolded protein response in health and disease. J Clin Invest 110 10 (2002) 1389-1398
51. Ramachandran N., Paul Root P., Jiang X., Hogg P., and Mutus B. Mechanism of transfer of NO from extracellular S-nitrosothiols. PNAS 98 (2001) 9539-9544
52. Nonaka H., Tsujino T., Watari Y., Emoto N., and Yokoyama M. Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine. Circulation 104 10 (2001) 1165-1170
53. Brierley E.J. Mitochondrial damage in human aging. Rev Clin Gerontol 7 (1997) 95-105
54. Matthias D., Becker C.H., Riezler R., and Kindling P.H. Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine. Atherosclerosis 122 (1996) 201-216
55. McCully K.S. Homocysteine and vascular disease. Nat Med 2 (1996) 386-389
56. Zhang C., Cai Y., Adachi M.T., et al. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 276 (2001) 35867-35874
57. 2 act synergistically to enhance mitochondrial damage. J Biol Chem 273 (1998) 30808-30817
58. Blackburn E.H. Structure and function of telomeres. Nature 350 (1991) 569-573
59. Harley C.B., Futcher A.B., and Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 345 (1990) 458-460
60. Vaziri H., Dragowska W., Allsopp R.C., Thomas T.E., Harley C.B., and Lansdorp P.M. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89 (1992) 10114-10118
61. Allsopp R.C., and Harley C.B. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219 (1995) 130-136
62. Sedivy J.M. Can ends justify the means? Telomeres and the mechanism of replicative senescence and immortalization in mammalian cells. Proc Natl Acad Sci USA 95 (1998) 9078-9081
63. Xu D., Neville R., and Finkel T. Homocysteine accelerates endothelial cell senescence. FEBS Lett 470 (2000) 20-24
64. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 2671 (1995) 1456-1462
65. Raffetto J., Leverkus M., Park H., and Menzoian J. Synopsis on cellular senescence and apoptosis. J Vasc Surg 34 1 (2001) 173-177
66. Kruman I.I., Culmsee C., Chan S.L., Kruman Y., Guo Z., Penix L., et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20 18 (2000) 6920-6926
67. Ratter F., Germer M., Fischbach T., Schulze-Osthoff K., Peter M.E., Droge W., et al. S-adenosylhomocysteine as a physiological modulator of Apo-1-mediated apoptosis. Int Immunol 8 7 (1996) 1139-1147
68. Zhang C., et al. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 276 (2001) 35867-35874
69. Suhara T., Mano T., Oliveira B.E., and Walsh K. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ Res 89 (2001) 13-19
70. Sata M., and Walsh K. Endothelial cell apoptosis induced by oxidized LDL is associated with the downregulation of the cellular caspase inhibitor FLIP. J Biol Chem 273 (1998) 33103-33106
71. Walsh K. Death receptor induced apoptosis: a new mechanism of homocysteine-mediated endothelial cell cytotoxicity. Hypertension 43 6 (2004) 1168-1170
72. Huang R., Yaong H., Chen S., and Lu Y. In vitro folate supplementation alleviates oxidative stress, mitochondria-associated death signalling and apoptosis induced by 7-ketocholesterol. BJ Nutr 92 6 (2004) 887-894
73. Medley T.L., Kingwell B.A., Gatzka C.D., Pillay P., and Cole T.J. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res 92 (2003) 1254-1261
74. Schutz R., Konig B., Hochstrasser B., Stolz P., and Imfeld D. Production of the tissue inibitor of metalloproteinase-2 (TIMP-2) and evaluation of its potential as anti-aging active. Int J Cos Sci 28 1 (2006) 69
75. Ross R. The pathogenesis of atherosclerosis. Nature 362 (1993) 801
76. Tyagi S.C. Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. Am J Physiol 274 (1998) C396-C405
77. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., and Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular MMP in vitro. J Clin Invest 98 (1996) 2572-2579
78. Radomski A., Sawicki G., Olson D.M., and Radomski M.W. The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Brit J Pharmacol 125 (1998) 1455-1462
79. Mujumdar V., Aru G., and Tyagi S. Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem 82 3 (2001) 491-500
80. Springman E.B., Angleton E.L., Birkedal-Hansen H., and Van Wart H.E. Multiple modes of activation of latent human fibroblast. Proc Natl Acad Sci USA 87 (1990) 364-368
81. Tyagi S.C., Ratajaska A., and Weber K.T. Myocardial matrix metalloproteinases: activation and localization. Mol Cell Biochem 126 (1993) 49-59
82. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 378 (1997) 151-160
83. Van Wart H.E., and Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity. Proc Natl Acad Sci USA 87 (1990) 5578-5582
84. Boushey C.J., Beresford S.A.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma hcy as a risk factor for vascular disease. JAMA 274 (1995) 1049-1057
85. Selhub J., Jacques P.F., Bostom A.G., et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332 (1995) 286
86. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324 (1991) 1149-1155
87. Ridker P.M., Stampfer M.J., and Rifai N. Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, hcy, lipoprotein (a), and standard cholesterol screening as predictors of PVD. JAMA 285 (2001) 2481-2485
88. Tyagi S., Rodriguez W., Patel A., Roberts A., Falcone J., Passmore J., et al. Hyperhomocysteinemic diabetic cardiomyopathy: oxidative stress, remodeling, and endothelial-myocyte uncoupling. J Cardiovasc Pharm Thera 10 1 (2005) 1-10
89. Tribouilloy C.M., Peltier M., Iannetta Peltier M.C., Trojetta F., Andrejak M., and Lesbre J.P. Plasma homocysteine and severity of thoracic aortic atherosclerosis. Chest 118 6 (2000) 1685-1689
90. Marcucci R., Betti I., Cecchi E., et al. Hyperhomocysteinemia and vitamin B6 deficiency: new risk markers for nonvalvular atrial fibrillation?. Am Heart J 148 3 (2004) 456-461
91. den Heijer M., Koster T., Blom H.J., Bos G.M., Briet E., Reitsma P.H., et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334 (1996) 759-762
92. Sutton-Tyrrell K., Bostom A., Selhub J., et al. High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation 96 (1997) 1745-1749
93. Li N., Chen Y.F., and Zou A.P. Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension 39 2Pt2 (2002) 443-448
94. Hankey G., and Eikelboom J. Homocysteine and stroke. Curr Opin Neurol 14 1 (2001) 95-102
95. Den Heijer T., Vermeer S.E., Clarke R., Outkerk M., Koudstaal P.J., Hofman A., et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 126 (2003) 170
96. Stewart R., Asonganyi B., and Sherwood R. Plasma homocysteine and cognitive impariment in an older British African-Caribbean population. J Am Geriatr Soc 50 (2002) 1227-1232
97. Riggs K.M., Spiro III A., Tucker K., and Rush D. Relations of vitamin B12, vitamin B6, folate and homocysteine to cognitive performance in the normative aging study. Am J Clin Nutr 63 (1996) 306-314
98. McCaddon A., Regland B., Hudson P., and Davies G. Functional vitamin B(12) deficiency and Alzheimer's disease. Neurology 58 (2002) 1395-1399
99. Clarke R., Smith D., Jobst K., Refsum H., Sutton L., and Ueland P.M. Folate, vitamin B-12, and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol 55 (1998) 1449-1455
100. Hogervorst E., Ribeiro H.M., Molyneux A., Budge M., and Smith A.D. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 59 (2002) 787-793
101. Elias P.K., Robbins M.A., Elias M.F., and Norris D.R. Plasma homocysteine, depressed mood, and cognitive function: the Maine-Syracuse study. Clin Chem Lab Med 43 3 (2005) A30
102. Kuhn W., Roebroek R., Blom H., van Oppenraaij D., Przuntek H., Kretschmer A., et al. Elevated plasma levels of homocysteine in Parkinson's disease. Eur Neurol 40 (1998) 225-227
103. Malaguarnera M., Ferri R.B., Alagona G., Carnemolla A., and Pennisi G. Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease. Clin Chem Lab Med 42 9 (2004) 1032-1035
104. van Meurs J.B., Dhonukshe-Rutten R.A., Pluijm S.M., et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350 (2004) 2033-2041
105. Wilcken D.E.L., and Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inher Metab Dis 20 (1997) 295-300
106. Behrman R.E. Nelson textbook of pediatrics. 17th ed. (2004), Saunders, Pennsylvania p. 406-8 [chapter 73]
107. Kraus J.P., Janosik M., Kozich V., et al. Cystathionine β-synthase mutations in homocystinuria. Hum Mutat 13 (1999) 362-375
108. Armbrecht H.J. Biologic theories of aging. J Lab Clin Med 138 4 (2001) 220-225
109. Kark J.D., Selhub J., Adler B., Gon J., Abramson J.H., Friedman G., et al. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Int Med 131 (1999) 321-330
110. Thomson S.W., Heimburger D.C., Cornwell P.E., Turner M.E., Sauberlich H.E., Fox L.M., et al. Correlates of total plasma homocysteine: folic acid, copper, and cervical dysplasia. Nutrition 16 (2000) 411-446
111. Kato I., Dnistrian A.M., Schwartz M., Toniolo P., Koenig K., Shore R.E., et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer 79 (1999) 1917-1922
112. Heijmans B.T., Gussekloo J., Kluft C., Droog S., Lagaay A.M., Knook D.L., et al. Mortality risk in men is associated with a common mutation in the methylene-tetrahydrofolate reductase gene. Eur J Hum Genet 7 (1999) 197-204
113. Fenech M., Aitken C., and Rinaldi J.R. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 19 (1998) 1163-1171
114. Oikawa S., Murakami K., and Kawanishi S. Oxidative damage to cellular and isolated DNA by homocysteine. Oncogene 22 (2003) 3530-3538
115. Nygard O., Vollset S.E., Refsum H., Stensvold I., Tverdal A., Nordrehaug J.E., et al. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA 274 (1995) 1526-1533
116. Mallamaci F., Zoccali C., Tripepi G., et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61 (2001) 609-614
117. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., and Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-236
118. Bostom A., Silbershatz H., Rosemberg I., Selhub J., and Wolf P. Nonfasting plasma total homocysteine level and all cause and cv disease mortality in the elderly Framingham men and women. Arch Intern Med 159 (1999) 1077-1080
119. Kark J.D., Selhub J., Adler B., et al. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med 131 5 (1999) 321-330
120. Hamerman D. Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. Qjm 98 7 (2005) 467-484
121. Braithwaite R.S., Col N.F., and Wong J.B. Estimating hip fracture morbidity, mortality and costs. JAGS 51 (2003) 364-370
122. Lecka-Czernik B., Moerman E.J., Grant D.F., Lehmann J.M., Manolagas S.C., and Jilka R.L. Divergent effects of selective peroxisome proliferator-activated receptor-[gamma]2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143 (2002) 2376-2384
123. Kaden J.J., Bickelhaupt S., Grobholz R., et al. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol 36 (2004) 57-66
124. Orentreich N., Matias J.R., DeFelice A., and Zimmerman J.A. Low methionine ingestion by rats extends life span. J Nutr 123 (1993) 269-274
125. Richie Jr. J.P., Leutzinger Y., Parthasarathy S., Malloy V., Orentreich N., and Zimmerman J.A. Methionine restriction increases blood glutathione and longevity in F344 rats. FASEB J 8 (1994) 1302-1307
126. Rattan S.I.S. Repeated mild heat shock delays ageing in cultured human skin fibroblasts. Biochem Mol Biol Int 45 (1998) 753-759
127. Mudd S.H., Levy H.L., and Skovby F. Disorders of transsulfuration. In: Scriver C.R., Beaudet A.L., Sly W.A., and Valle D. (Eds). The metabolic and molecular bases of inherited disease (1995), McGraw-Hill, New York 1279